We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
(+7.8%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$37.6M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$29.3M |
| 3 |
Biogen
BIIB
|
+$27.4M |
| 4 |
Home Depot
HD
|
+$22.7M |
| 5 |
Cisco
CSCO
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$23.6M |
| 2 |
TJX Companies
TJX
|
+$19.3M |
| 3 |
FedEx
FDX
|
+$16.4M |
| 4 |
Intuit
INTU
|
+$14.7M |
| 5 |
Corning
GLW
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.18% |
| 2 | Technology | 17.19% |
| 3 | Financials | 12.85% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Communication Services | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$3.9T
| $38.3M | 0.61% |
686,880
+33,180
| +5% | +$1.79M |
|
27
Abbott
ABT
$180B
| $38.3M | 0.61% |
627,510
-1,529
| -0.2% | -$92.7K |
|
28
Berkshire Hathaway Class B
BRK.B
$1.07T
| $37.9M | 0.6% |
202,794
+13,438
| +7% | +$2.62M |
|
|
29
Broadcom
AVGO
$1.82T
| $37.2M | 0.59% |
+1,532,450
| New | +$37.6M |
|
30
TAL Education Group
TAL
$5.71B
| $37.2M | 0.59% |
1,010,300
+109,000
| +12% | +$4.29M |
|
31
Applied Materials
AMAT
$426B
| $37.1M | 0.59% |
802,437
+106,748
| +15% | +$5.5M |
|
32
Salesforce
CRM
$134B
| $37M | 0.59% |
271,374
+44,342
| +20% | +$5.66M |
|
|
ALXN
33
DELISTED
Alexion Pharmaceuticals
ALXN
| $36.5M | 0.58% |
294,042
+32,923
| +13% | +$3.85M |
|
34
American Express
AXP
$223B
| $36.5M | 0.58% |
371,963
-14,733
| -4% | -$1.45M |
|
35
Agilent Technologies
A
$39.1B
| $34.5M | 0.55% |
557,083
+139,046
| +33% | +$9.07M |
|
36
Comcast
CMCSA
$79.7B
| $32.2M | 0.51% |
980,268
+311,350
| +47% | +$10.1M |
|
37
Oracle
ORCL
$331B
| $32M | 0.51% |
727,189
+299,076
| +70% | +$13.8M |
|
38
Emerson Electric
EMR
$82.9B
| $31.5M | 0.5% |
455,900
+184,047
| +68% | +$12.9M |
|
39
PTC
PTC
$13.7B
| $30.6M | 0.48% |
325,781
+76,958
| +31% | +$6.65M |
|
40
PayPal
PYPL
$49.5B
| $30.4M | 0.48% |
365,349
+34,471
| +10% | +$2.75M |
|
41
Colgate-Palmolive
CL
$72.6B
| $30.3M | 0.48% |
466,992
-26,825
| -5% | -$1.75M |
|
42
Illumina
ILMN
$29.4B
| $29.5M | 0.47% |
108,590
+8,944
| +9% | +$2.28M |
|
43
Cigna
CI
$76.6B
| $27.9M | 0.44% |
164,242
-32,220
| -16% | -$5.58M |
|
44
Citigroup
C
$222B
| $27.2M | 0.43% |
406,689
-81,977
| -17% | -$5.64M |
|
45
Wells Fargo
WFC
$261B
| $27.1M | 0.43% |
489,700
+7,248
| +2% | +$388K |
|
46
Texas Instruments
TXN
$255B
| $26.5M | 0.42% |
240,197
-26,793
| -10% | -$2.9M |
|
47
Adobe
ADBE
$89.5B
| $26.3M | 0.42% |
107,680
+18,563
| +21% | +$4.39M |
|
48
Allstate
ALL
$66.9B
| $26M | 0.41% |
285,016
+22,296
| +8% | +$2.12M |
|
49
Intuitive Surgical
ISRG
$121B
| $26M | 0.41% |
162,879
-41,595
| -20% | -$6.34M |
|
50
Merck
MRK
$324B
| $25.8M | 0.41% |
444,568
-171,066
| -28% | -$9.65M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2018 Portfolio in Review
As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.
- Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
- Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
- Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
- Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
- Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
- Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
- Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.
Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.